MacroGenics (MGNX) PT Raised to $21 at Stifel

May 6, 2020 4:28 AM

Stifel analyst Stephen Willey raised the price target on MacroGenics (NASDAQ: MGNX) to $21.00 (from $20.00) while maintaining a Buy rating.

No results found